Genotoxicity associated with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Maia Filho PA, Almeida Filho TP, Moreina-Nunes CFA, Burbano RR, de Lemos JAR, de Oliveira EHC, Cavalcanti BC, Pereira JF, Barbosa MC, Duarte FB, de Castro MF, Quixadá ATS, Lemes RPG.
Maia Filho PA, et al. Among authors: burbano rr.
Environ Mol Mutagen. 2018 Apr;59(3):260-262. doi: 10.1002/em.22164. Epub 2017 Dec 29.
Environ Mol Mutagen. 2018.
PMID: 29285791
No abstract available.